or Try an Advanced Search...

    Technical Analysis for ALEC - Alector, Inc.

    Grade Last Price % Change Price Change
    D 5.02 2.03% 0.10
    ALEC closed up 2.03 percent on Friday, November 1, 2024, on 1.29 times normal volume. It ran into resistance at its 50 day moving average.
    Earnings due: Nov 5
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical ALEC trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Gapped Up Strength 0.00%
    Fell Below 50 DMA Bearish 2.03%
    50 DMA Support Bullish -1.57%
    Pocket Pivot Bullish Swing Setup -1.57%
    Crossed Above 50 DMA Bullish -0.99%
    Doji - Bearish? Reversal -0.99%
    50 DMA Resistance Bearish -0.99%
    20 DMA Support Bullish -0.99%
    Older End-of-Day Signals for ALEC ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 20 hours ago
    Rose Above 50 DMA about 21 hours ago
    Gap Up Partially Closed about 22 hours ago
    Gapped Up (Partial) about 22 hours ago
    Rose Above Previous Day's High about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ALEC Chart by TradingView
    Basic chart:

    Profile

    Alector is pioneering immuno-neurology, a novel therapeutic approach to counteract the multiple pathologies that cause degenerative brain disorders by restoring healthy immune function to the brain. Supporting its scientific approach, the Company’s Discovery Platform enables them to advance a broad portfolio of product candidates, validated by human genetics, which they believe will improve the probability of technical success of these product candidates and shorten the development timelines to bring these therapies to patients.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunology Immune System Genetics Urology Neurology Brain Disorders

    Is ALEC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 1 Precision BioSciences (DTIL) Surges 6.1%: Is This an Indication of Further Gains?
    Oct 30 Is Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans?
    Sep 19 Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
    Sep 19 Alector (NASDAQ:ALEC) investors are sitting on a loss of 77% if they invested three years ago
    Sep 17 Ascendis Pharma (ASND) Moves 17.1% Higher: Will This Strength Last?
    Aug 29 Alector to Participate in Upcoming Healthcare Conferences
    Aug 23 Director Richard Scheller Sells 44,250 Shares of Alector Inc (ALEC)
    Aug 9 Alector Second Quarter 2024 Earnings: Beats Expectations
    Aug 9 Alector, Inc. (ALEC) Q2 2024 Earnings Call Transcript
    Aug 7 Alector (ALEC) Reports Q2 Loss, Lags Revenue Estimates
    See more ALEC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.9
    52 Week Low 3.66
    Average Volume 498,919
    200-Day Moving Average 5.45
    50-Day Moving Average 5.06
    20-Day Moving Average 4.86
    10-Day Moving Average 4.85
    Average True Range 0.29
    RSI (14) 52.15
    ADX 12.81
    +DI 24.17
    -DI 19.44
    Chandelier Exit (Long, 3 ATRs) 4.49
    Chandelier Exit (Short, 3 ATRs) 5.07
    Upper Bollinger Bands 5.29
    Lower Bollinger Band 4.44
    Percent B (%b) 0.68
    BandWidth 17.58
    MACD Line -0.01
    MACD Signal Line -0.05
    MACD Histogram 0.0416
    Fundamentals Value
    Market Cap 476.93 Million
    Num Shares 95 Million
    EPS -1.71
    Price-to-Earnings (P/E) Ratio -2.94
    Price-to-Sales 6.36
    Price-to-Book 3.77
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.33
    Resistance 3 (R3) 5.34 5.25 5.28
    Resistance 2 (R2) 5.25 5.17 5.24 5.26
    Resistance 1 (R1) 5.13 5.12 5.19 5.12 5.24
    Pivot Point 5.04 5.04 5.07 5.04 5.04
    Support 1 (S1) 4.93 4.96 4.99 4.92 4.80
    Support 2 (S2) 4.84 4.91 4.83 4.78
    Support 3 (S3) 4.72 4.84 4.76
    Support 4 (S4) 4.71